Dokter Kondrosarkoma di Luar Negeri — Halaman 2

Dr. Amir adalah spesialis dalam bedah penyelamatan anggota tubuh untuk kanker tulang dan jaringan lunak di Sourasky Medical Center Israel (Ichilov).

• Menjalani pelatihan fellowship dalam onkologi ortopedi di National Cancer Institute AS dan University of Toronto
• Anggota aktif dari American Musculoskeletal Tumor Society (MSTS) dan International Society of Limb Salvage (ISOLS)
• Pemenang berbagai penghargaan, termasuk Tannenbaum Grant untuk keunggulan dalam onkologi bedah
• Berfokus pada sarkoma, dengan keahlian dalam kasus-kasus kompleks yang memerlukan teknik rekonstruksi

Memimpin departemen yang didedikasikan untuk lesi tulang metastatik di Ichilov Medical Center – salah satu rumah sakit terbesar di Israel.

• Berespesialisasi khusus dalam ortopedi onkologi, menangani kanker tulang.
• Menyelesaikan magang klinis tingkat lanjut di Israel dan Amerika Serikat.
• Memegang posisi akademik senior sebagai Profesor di Universitas Tel Aviv.
• Menempuh pendidikan di Universitas Ibrani Yerusalem yang bergengsi.

Profesor Keil memimpin Klinik Radiologi Diagnostik dan Intervensi di Rumah Sakit Akademik Solingen, dengan spesialisasi pencitraan tingkat lanjut untuk kasus-kasus kompleks.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Ahli dalam MRI, CT, dan intervensi yang dipandu ultrasonografi
• Mantan dokter terkemuka di Rumah Sakit Universitas Aachen
• Spesialis dalam pencitraan cross-sectional untuk semua wilayah tubuh

Spesialisasi dalam viroterapi – salah satu bidang imunologi terbaru – Dr. Jaunalksne membawa 30+ tahun pengalaman dalam mengobati kondrosarkoma.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Fokus pada pendekatan imunologis inovatif untuk pengobatan kanker

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Alemdar spesialis dalam kondrosarkoma di Medical Park Antalya, membawa keahlian onkologi terfokus pada kasus kanker tulang langka.

• Tersertifikasi dalam onkologi medis dengan pelatihan ekstensif
• Pengalaman di berbagai rumah sakit universitas terkemuka di Turki
• Spesialisasi dalam penyakit dalam sebelum spesialisasi onkologi

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Prof. Elke Jaeger adalah salah satu spesialis sarkoma ternama di Jerman menurut peringkat Focus, dengan pengalaman praktik selama 35+ tahun.

• Kepala Onkologi dan Hematologi di Klinik Nordwest
• Diakui sebagai salah satu ahli onkologi terbaik di Jerman
• Spesialisasi dalam pengobatan sarkoma

Dr. Ahmet Bilici adalah seorang onkolog medis ternama yang berspesialisasi dalam perawatan sarkoma dan kanker paru-paru di Rumah Sakit Universitas Medipol Mega.

• Pengalaman dedikasi lebih dari 20 tahun di bidang onkologi
• Keahlian dalam menangani kasus sarkoma yang langka dan kompleks
• Diakui sebagai salah satu spesialis sarkoma terkemuka di Turki

Dr. Yildiz berspesialisasi dalam tumor neuroendokrin dan telah menulis lebih dari 17 artikel internasional yang ditinjau sejawat, termasuk mengenai kondisi terkait kondrosarkoma.

• Menerbitkan penelitian tentang kasus tumor langka seperti pemfigus paraneoplastik dan timoma
• Keahlian dalam mendiagnosis dan menangani kanker terkait endokrin yang kompleks
• Bekerja di Rumah Sakit Universitas Medipol Mega – pusat medis terkemuka di Turki

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Spesialisasi dalam onkologi radiasi di Universitas Marmara, dengan fokus pada pengobatan kondrosarkoma.

• Terlatih di Fakultas Kedokteran Universitas Marmara yang ternama
• Spesialisasi dalam onkologi radiasi dari 2012-2016
• Lulus dari program sarjana Fakultas Kedokteran Universitas Marmara (Bahasa Inggris)
• Menyediakan rencana terapi radiasi yang disesuaikan secara personal